The FDA announced the availability of a draft guidance designed to assist the research community in interpreting requirements for submitting reports of unanticipated problems such as certain adverse events reports to Institutional Review Board (IRB).
The agency is especially interested in getting views from consumers, pharmacies, manufacturers, wholesalers, and researchers.
An estimated three out of five people with Type 2 diabetes have at least one of the other serious health problems commonly associated with the disease.
A nationwide recall of griseofulvin oral suspension 125 mg/5 ml
Misbranding of Ziagen as Combivir.
An educational program is now available to help patients learn to self-administer Vivaglobin, the first subcutaneously administered immunoglobulin for the treatment of primary immunodeficiency.
RediClinicLLC has entered into a 50-50 partnership with Memorial Hermann, called RCMH LLC, for the operation of all RediClinics in the Greater Houston area.
Can a marriage between a highly automated pharmacy chain that operates in grocery stores and a company that provides home care services and operates retail health clinics be successful?
The FDA has approved the combination of sitagliptin (Januvia, Merck) and metformin for the treatment of Type 2 diabetes.
Patients suffering from irritable bowel syndrome with constipation or chronic constipation will no longer have the option of treatment with tegaserod (Zelnorm).
Liver transplant patients with a prior history of hepatitis B (HBV) can now receive HepaGam B, from Cangene Corp., to prevent reinfection.
The pharmacy world is abuzz over the broadcast of a "20/20" report on pharmacy medication errors.
RediClinic LLC recently opened eight healthcare clinics in leased space inside Richmond, Va.-area Wal-Mart Supercenters.
RediClinic LLC recently opened eight healthcare clinics in leased space inside Richmond, Va.-area Wal-Mart Supercenters.
NACDS president/CEO Steven Anderson issued a statement regarding the recent passage of the concurrent budget resolution in the House of Representatives.
In March, Drug Topics conducted an exclusive on-line poll that asked, Should condoms be locked up in pharmacies?
The Counterfeit Drug Prevention Act of 2007 amends the Federal Food, Drug, and Cosmetic Act.
N.Y. pharmacist Howard Topchik has been charged with leading a drug ring that sold prescription Vicodin without valid prescriptions.
AVA Pharmaceuticals announced that it has settled a patent infringement suit with Impax Laboratories and Purdue Pharma regarding Impax's generic versions of Purdue's OxyContin.
The FTC launched a civil investigation requesting that Bristol-Myers Squibb turn over key documents and information surrounding a reverse-payment deal it and Sanofi-Aventis made with generic firm Apotex to delay market entry of generic clopidogrel bisulfate (Plavix).
Patients with protein C deficiency will now have a new treatment available to them
A study of physicians has found that many report facing significant barriers to fully implementing e-prescribing.
A new report from the Campaign for America's Future argues that Medicare Part D and beneficiaries would save $30 billion in prescription drug costs if the federal government negotiated Medicare drug prices with pharmaceutical companies.
Combination vaccine providing coverage for both hepatitis A and B, can now be administered in an accelerated dosing schedule.
X-rays performed with iodine dye increases risk for kidney failure in patients with impaired kidney function.
Rhophylac, an anti-D Rh immunoglobulin, has been approved by the FDA for the treatment of immune thrombocytopenic purpura (ITP)
URAC has secured more than 10 organizations as beta-test sites for its accreditation standards for pharmacy benefit managers.
Consumers who have used retail clinics are open to treatment for a wider range of medical treatments
Taking excessive doses of a common vitamin in an attempt to defeat drug screening tests may send the user to the hospital
Would you like to receive updated drug labeling information electronically, rather than in paper insert form? The FDA is planning a hearing to explore this issue.